Hepcdac 60
In stock
Description
Hepcdac 60 contains the active pharmaceutical ingredient Daclatasvir (60 mg), a prescription antiviral medication primarily used in combination with Sofosbuvir to treat chronic Hepatitis C virus (HCV) infections. It acts as an NS5A inhibitor to stop the virus from multiplying.
Specifications
| Strength | 60 Mg |
|---|---|
| Primary Indication | Chronic Hepatitis C (HCV) |
| Prescription Status | Prescription-Only Drug (Rx) |
| Storage Condition | Store below 30°C, protect from moisture and light |
| Dosage Form | Oral Tablet (film-coated) |
| Drug Class | NS5A Inhibitor (Direct-Acting Antiviral) |
